However, we could not rule out the capability of these two assays in detecting tau seeding activity in the brain of individuals with PSP/CBD and the majority of PiD, which remains to be confirmed by recruiting more tauopathy cases to the study. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.